Pharmaceutical Company
Orphan Drug Tax Credit provisions in the Build Back Better (H.R. 5376). FDA - rare and orphan disease issues; 
Prescription drug coverage and payment policies; 
Medical innovation issues. Fiscal year 2022 LHHS appropriations report language on Wilson's Disease, Myasthenia Gravis;
Neuromyelitis Optica Spectrum Disorder (NMOSD);
Low volume DRG payments for rare disease therapies and Home Infusion.
TAX - Taxation/Internal Revenue Code HCR - Health Issues BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
ANDREA LARUE LISA GERMAN FOSTER ANDREA LARUE LISA GERMAN FOSTER LISA GERMAN FOSTER